Acrobiosystems for English
icon_bulk_orderAchat groupé/Commande rapide
user
  1. Tableau de bord
  2. Mon profil
  3. Mon adresse
  4. Mes commandes
  5. Adhésion à Acro
Connexion Inscription
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
Il n'y a pas de produit dans le panier !
Mon panier|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > GDNF

GDNF

Brief Information

Name:Glial cell line-derived neurotrophic factors
Target Synonym:Glial Cell Line-Derived Neurotrophic Factors
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:NDA/BLA

Product ListCompare or Buy

Product> Filter Results
Par statut du produit :
Par catégorie de produit :
Par espèce :
Par étiquette :
Par conjugaison :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
GDF-M5245 Mouse Mouse GDNF / ATF Protein, His Tag (MALS verified)
GDF-M5245-structure
GDF-M5245-sds
GDF-H5219 Human Human GDNF / ATF / hGDNF Protein, premium grade
GDF-H5219-structure
GDF-H5219-sds
ACRO Quality

Part of Bioactivity data

GDF-M5245-MALS-HPLC
GDNF MALS images

The purity of Mouse GDNF, His Tag (Cat. No. GDF-M5245) is more than 90% and the molecular weight of this protein is around 40-50 kDa verified by SEC-MALS.

GDF-H5219-ELISA
GDNF ELISA

Immobilized Human GDNF Protein, premium grade (Cat. No. GDF-H5219) at 2 μg/mL (100 μL/well) can bind Human GFR alpha-1, His Tag (Cat. No. GF1-H5224) with a linear range of 0.2-4 ng/mL (QC tested).

Protocol

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
AAV2-GDNF AB-1005; AMT-140 Phase 2 Clinical Lund University Foundation, National Institute Of Neurological Disorders And Stroke, Uniqure Biopharma Bv, Uc San Francisco Parkinson Disease; Multiple System Atrophy Details
NRO-1 NRO-1; SI-01 Phase 2 Clinical Senju Pharmaceutical Co Ltd Xerophthalmia Details
AMT-130 AAV5-miSNP15; AAV5-miSNP7; AMT-130; AAV5-miHtt12 Phase 2 Clinical Amsterdam Molecular Therapeutics, Uniqure Huntington Disease Details
AAV2-GDNF AB-1005; AMT-140 Phase 2 Clinical Lund University Foundation, National Institute Of Neurological Disorders And Stroke, Uniqure Biopharma Bv, Uc San Francisco Parkinson Disease; Multiple System Atrophy Details
NRO-1 NRO-1; SI-01 Phase 2 Clinical Senju Pharmaceutical Co Ltd Xerophthalmia Details
AMT-130 AAV5-miSNP15; AAV5-miSNP7; AMT-130; AAV5-miHtt12 Phase 2 Clinical Amsterdam Molecular Therapeutics, Uniqure Huntington Disease Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
E-Mail
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Laisser un message

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap